China Reform Health Management and Services Group Past Earnings Performance
Past criteria checks 0/6
China Reform Health Management and Services Group has been growing earnings at an average annual rate of 5.7%, while the Healthcare industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 23.9% per year.
Key information
5.7%
Earnings growth rate
6.0%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 23.9% |
| Return on equity | -5.6% |
| Net Margin | -23.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How China Reform Health Management and Services Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 322 | -76 | 183 | 0 |
| 31 Dec 23 | 330 | -80 | 190 | 1 |
| 30 Sep 23 | 337 | -77 | 190 | 3 |
| 30 Jun 23 | 329 | -97 | 176 | 9 |
| 31 Mar 23 | 329 | -79 | 164 | 9 |
| 31 Dec 22 | 311 | -84 | 157 | 10 |
| 30 Sep 22 | 285 | -165 | 158 | 12 |
| 30 Jun 22 | 282 | -152 | 161 | 14 |
| 31 Mar 22 | 263 | -169 | 156 | 18 |
| 01 Jan 22 | 253 | -176 | 163 | 16 |
| 30 Sep 21 | 240 | -208 | 148 | 23 |
| 30 Jun 21 | 220 | -219 | 146 | 20 |
| 31 Mar 21 | 218 | -228 | 152 | 17 |
| 31 Dec 20 | 207 | -243 | 142 | 16 |
| 30 Sep 20 | 145 | 2 | 124 | 8 |
| 30 Jun 20 | 138 | 9 | 132 | 4 |
| 31 Mar 20 | 130 | -4 | 135 | 5 |
| 31 Dec 19 | 130 | 17 | 133 | 6 |
| 30 Sep 19 | 103 | -221 | 128 | 5 |
| 30 Jun 19 | 105 | -211 | 133 | 3 |
| 31 Mar 19 | 100 | -179 | 124 | 1 |
| 31 Dec 18 | 95 | -188 | 129 | 1 |
| 30 Sep 18 | 34 | -131 | 116 | 18 |
| 30 Jun 18 | 40 | -180 | 144 | 18 |
| 31 Mar 18 | 72 | -192 | 166 | 19 |
| 31 Dec 17 | 99 | -172 | 186 | 18 |
| 30 Sep 17 | 181 | -41 | 186 | 0 |
| 30 Jun 17 | 199 | 4 | 153 | 0 |
| 31 Mar 17 | 200 | 16 | 172 | 0 |
| 31 Dec 16 | 217 | 28 | 169 | 0 |
| 30 Sep 16 | 217 | 35 | 187 | 0 |
| 30 Jun 16 | 207 | 12 | 171 | 0 |
| 31 Mar 16 | 205 | 15 | 167 | 0 |
| 31 Dec 15 | 194 | 23 | 159 | 0 |
| 30 Sep 15 | 181 | -74 | 164 | 0 |
| 30 Jun 15 | 182 | -28 | 182 | 0 |
| 31 Mar 15 | 190 | 5 | 152 | 0 |
| 31 Dec 14 | 195 | 25 | 131 | 0 |
| 30 Sep 14 | 192 | 13 | 98 | 0 |
| 30 Jun 14 | 193 | 15 | 92 | 0 |
| 31 Mar 14 | 210 | 12 | 84 | 0 |
| 31 Dec 13 | 206 | 13 | 90 | 0 |
| 30 Sep 13 | 223 | 23 | 111 | 0 |
| 30 Jun 13 | 226 | 21 | 106 | 0 |
Quality Earnings: 000503 is currently unprofitable.
Growing Profit Margin: 000503 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 000503 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.7% per year.
Accelerating Growth: Unable to compare 000503's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 000503 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-1%).
Return on Equity
High ROE: 000503 has a negative Return on Equity (-5.56%), as it is currently unprofitable.